Total Payments
$530.23
2024 Payments
$22.44
Companies
12
Transactions
19
Medicare Patients
1,922
Medicare Billing
$218,842
Payment Breakdown by Category
Food & Beverage$530.23 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $530.23 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $111.53 | 1 | $0 (2023) |
| DePuy Synthes Sales Inc. | $107.76 | 1 | $0 (2020) |
| ABBVIE INC. | $105.89 | 4 | $0 (2023) |
| Allergan, Inc. | $43.54 | 3 | $0 (2021) |
| GENZYME CORPORATION | $35.53 | 2 | $0 (2024) |
| OptiNose US, Inc. | $32.36 | 2 | $0 (2019) |
| Lucid Diagnostics Inc. | $21.43 | 1 | $0 (2022) |
| Spirox Inc | $20.24 | 1 | $0 (2017) |
| Stryker Corporation | $14.74 | 1 | $0 (2019) |
| Entellus Medical, Inc. | $13.85 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.44 | 1 | GENZYME CORPORATION ($22.44) |
| 2023 | $217.42 | 5 | Horizon Therapeutics plc ($111.53) |
| 2022 | $21.43 | 1 | Lucid Diagnostics Inc. ($21.43) |
| 2021 | $11.61 | 1 | Allergan, Inc. ($11.61) |
| 2020 | $107.76 | 1 | DePuy Synthes Sales Inc. ($107.76) |
| 2019 | $92.12 | 6 | OptiNose US, Inc. ($32.36) |
| 2018 | $12.50 | 1 | Novartis Pharmaceuticals Corporation ($12.50) |
| 2017 | $44.95 | 3 | Spirox Inc ($20.24) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Immunology | ||||||
| 09/20/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $29.47 | General |
| 06/23/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $20.49 | General |
| 05/22/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $26.98 | General |
| 05/15/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $111.53 | General |
| Category: TEPEZZA | ||||||
| 05/12/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $28.95 | General |
| 08/15/2022 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $21.43 | General |
| 10/28/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: FACIAL AESTHETICS | ||||||
| 03/04/2020 | DePuy Synthes Sales Inc. | TRUMATCH (Device) | Food and Beverage | In-kind items and services | $107.76 | General |
| Category: Ortho-Knee | ||||||
| 11/25/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/14/2019 | GENZYME CORPORATION | DUPIXENT (Drug), DUPIXENT | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2019 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $12.79 | General |
| 04/15/2019 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 03/11/2019 | Stryker Corporation | NONE (Device) | Food and Beverage | Cash or cash equivalent | $14.74 | General |
| Category: NONE | ||||||
| 01/29/2019 | Allergan Inc. | — | Food and Beverage | In-kind items and services | $19.14 | General |
| 03/21/2018 | Novartis Pharmaceuticals Corporation | CIPRODEX (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: OTOLARYNGOLOGY | ||||||
| 10/04/2017 | Entellus Medical, Inc. | XprESS Multi-Sinus Dilation System (Device) | Food and Beverage | Cash or cash equivalent | $13.85 | General |
| Category: Otolaryngology | ||||||
| 07/11/2017 | Spirox Inc | Latera (Device) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: Nasal Implant | ||||||
| 06/28/2017 | Mylan Specialty L.P. | Dymista (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: Respiratory and Allergy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 601 | 775 | $185,246 | $70,485 |
| 2022 | 11 | 497 | 670 | $152,824 | $60,467 |
| 2021 | 12 | 463 | 590 | $130,525 | $56,795 |
| 2020 | 8 | 361 | 487 | $75,427 | $31,095 |
Total Patients
1,922
Total Services
2,522
Medicare Billing
$218,842
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 199 | $27,860 | $12,951 | 46.5% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 76 | 83 | $26,975 | $11,017 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 103 | $20,085 | $8,362 | 41.6% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 14 | 15 | $21,000 | $8,271 | 39.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 89 | 89 | $15,130 | $6,969 | 46.1% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2023 | 14 | 22 | $16,500 | $4,802 | 29.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 57 | $7,410 | $3,471 | 46.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 39 | 40 | $6,800 | $2,566 | 37.7% |
| 31579 | Exam to assess movement of vocal cord flaps using an endoscope | Office | 2023 | 18 | 18 | $7,110 | $2,564 | 36.1% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 27 | 28 | $11,421 | $2,466 | 21.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 25 | 26 | $5,070 | $2,318 | 45.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,890 | $2,161 | 31.4% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Facility | 2023 | 21 | 28 | $9,100 | $1,326 | 14.6% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 36 | 41 | $3,895 | $1,243 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 138 | 248 | $48,360 | $21,876 | 45.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $22,790 | $9,355 | 41.0% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 55 | 64 | $20,800 | $8,441 | 40.6% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2022 | 13 | 19 | $13,750 | $4,250 | 30.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 35 | $8,050 | $3,511 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 45 | $6,300 | $2,855 | 45.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 52 | $6,760 | $2,835 | 41.9% |
| 70486 | Ct scan of face without contrast | Office | 2022 | 22 | 23 | $9,729 | $2,326 | 23.9% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 41 | 45 | $4,275 | $1,478 | 34.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 16 | 16 | $3,120 | $1,423 | 45.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,870 | $949.85 | 50.8% |
About Dr. David Powell, MD
Dr. David Powell, MD is a Plastic Surgery within the Head & Neck healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1649242652.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Powell, MD has received a total of $530.23 in payments from pharmaceutical and medical device companies, with $22.44 received in 2024. These payments were reported across 19 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($530.23).
As a Medicare-enrolled provider, Powell has provided services to 1,922 Medicare beneficiaries, totaling 2,522 services with total Medicare billing of $218,842. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Plastic Surgery within the Head & Neck
- Other Specialties Otolaryngology
- Location Columbus, OH
- Active Since 02/03/2006
- Last Updated 10/11/2023
- Taxonomy Code 207YX0007X
- Entity Type Individual
- NPI Number 1649242652
Products in Payments
- TEPEZZA (Drug) $111.53
- TRUMATCH (Device) $107.76
- Xhance (Drug) $32.36
- DUPIXENT (Biological) $22.44
- Latera (Device) $20.24
- NONE (Device) $14.74
- XprESS Multi-Sinus Dilation System (Device) $13.85
- DUPIXENT (Drug) $13.09
- CIPRODEX (Drug) $12.50
- BOTOX (Biological) $11.61
- Dymista (Drug) $10.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.